Dr. Goli Vasu Babu

Dr. G. Vasu Babu is an expert medical oncologist and BMT specialist at HCG Vijayawada. He is known for his expertise in administering systemic therapies for a wide range of cancers. Dr. Vasu Babu completed his DNB and DM specialization programs at Tata Memorial Hospital, one of India’s prestigious medical institutes. His compassionate and patient-centric approach has earned him the respect and admiration of his patients and their families.

• Samanta RP, Babu GV. Mycobacterium Tuberculosis Infection at Pacemaker Implantation Site. J Assoc Physicians India. 2017;65(2):88-89.

• Goli VB, Jain R, Bhat G, Sainani A, Advani SH. Musculoskeletal chronic graft versus host disease - A rare complication of allogeneic hematopoietic stem cell transplantation: A case report and review of its literature. South Asian J Cancer. 2017;6(4):150.

• Goli VB, Jain R, Bhat G, Sainani A, Advani SH. Monoclonal gammopathy in chronic lymphocytic leukemia: A case report and review of its literature. Indian J Med Paediatr Oncol Indian J Med Paediatr Oncol 2018;39:257-9.

• Bhat, Ganapathi & Goli, Vasu & Patel, Rajas & Jain, Reetu. (2017). Loss of Human Epidermal Growth Factor Receptor 2 (HER-2) Expression after Trastuzumab Treatment in Locally Advanced Breast Cancer: A Case Report. Annals of International Medical and Dental Research. 3. 10.21276/aimdr.2017.3.6.MC1.

• Goli, Vasu & Shah, Preet & Bhat, Ganapathi & Nagral, Aabha. (2019). Post-transplant Epstein–Barr Virus-Related Lymphoproliferative Disorder. Indian journal of medical and pediatric oncology.

• S, Goli VB, Thorat. J Methotrexate leukoencephalopathy Cancer Res Stat Treat 2019;2:261-2

• Patil V, Noronha V, Dhumal SB, et al. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomized, phase 3 trial. Lancet Glob Health. 2020;8(9):e1213-e1222.

• Laboni Sarkar, Vasu Babu Goli, Nandini Menon, Vijay Maruti Patil, Vanita Noronha, Kumar Prabhash et.al Vaccination practices, efficacy, and safety in adults with cancer: A narrative review Cancer Res Stat Treat 2021;4:505-15.

• Mirgh S, Gokarn A, Punatar S, Chichra A, Singh A, Rajendra A, Vasu Babu Goli et al Clinical course of severe COVID-19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHD. Transpl Infect Dis. 2021 Aug;23(4):e13576.

• Jain H, Sengar M, Goli VB, et al. Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia. Blood Adv. 2021;5(17):3436-3444.

• Babu V, Yadav S, Thorat J, et al. Subcutaneous Panniculitis-Like T-Cell Lymphoma: Clinical Features and Outcomes from a Single Tertiary Center. Indian J Hematol Blood Transfus. 2021;37(4):697-698.

• Mirgh SP, Gokarn A, Rajendra A, Vasu Babu Goli et al Clinical characteristics, laboratory parameters, and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India. Cancer Med. 2021 Dec;10(24):8777-8788.